Showing results (1-10 of 2,343) with videos related to
Sort By:
Pageof 235
Molecules (Basel, Switzerland)|September 29, 2017
Current Development Status of MEK InhibitorsYing Cheng, Hongqi TianNeuroscience|April 29, 2021
Neuroprotective Effect of a New Free Radical Scavenger HL-008 in an Ischemia-Reperfusion Injury Rat ModelYahong Liu, Ying Cheng, Wei Zhang, et al.International Journal of Cancer|January 11, 2019
A benzoxazole compound as a novel MEK inhibitor for the treatment of RAS/RAF mutant cancerYing Cheng, Xingkai Wang, Xiangying Xia, et al.Oxidative Medicine and Cellular Longevity|August 18, 2018
The Protective Effect of New Compound XH-103 on Radiation-Induced GI SyndromeYinping Dong, Ying Cheng, Qinlian Hou, et al.Frontiers in Pharmacology|October 9, 2023
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitorYahong Liu, Ying Cheng, Gongchao Huang, et al.Journal of Cellular and Molecular Medicine|January 22, 2019
The protective effects of XH-105 against radiation-induced intestinal injuryYing Cheng, Yinping Dong, Qinlian Hou, et al.Bioorganic Chemistry|March 8, 2016
Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitorsNa Liu, Yanfen Wang, Gongchao Huang, et al.Journal of Drug Targeting|July 26, 2019
Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutationsLongfei Miao, Hongqi TianChemistry, an Asian Journal|May 19, 2018
N-Heterocyclic Carbene-Protected Ag Nanoparticles Immobilized on Polyacrylonitrile Fiber as Efficient Catalysts for a Three-Component Coupling ReactionJian Cao, Hongqi TianJournal of Drug Targeting|February 17, 2018
Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapyKui Li, Hongqi TianPageof 235